Portugal – Antineoplastic and immunomodulating agents – 251A000055 - C.Central Medicamentos 2025 - 1410/2024 - NILOTINIB
Unidade Local de Saúde Santa Maria, E.P.E. awarded a contract of undisclosed value to TEVA PHARMA-PROD. FARMACÊUT, LDA for Construction & Public Works in May 2025 — one of 2,122 awards this buyer has made.
Buying agency
Unidade Local de Saúde Santa Maria, E.P.E.Winning supplier
TEVA PHARMA-PROD. FARMACÊUT, LDAContract description
Portugal – Antineoplastic and immunomodulating agents – 251A000055 - C.Central Medicamentos 2025 - 1410/2024 - NILOTINIB - II
Related awards · Unidade Local de Saúde Santa Maria, E.P.E.
2,122 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-143447-2026IMI - IMAG.MED.INTEGRADAS, SA€495M02 Mar 2026 Professional Services
- ocds-ted-41448-2026Ambimed - Gestão Ambiental, Lda.€172M20 Jan 2026 Professional Services
- ocds-ted-770298-2024LAB. PFIZER, LDA€30.6M17 Dec 2024 Construction
Other wins · TEVA PHARMA-PROD. FARMACÊUT, LDA
4 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-587975-2025Unidade Local de Saúde Santa Maria, E.P.E.€130K09 Sep 2025 Construction
- ocds-ted-620806-2025Unidade Local de Saúde Santa Maria, E.P.E.€104K23 Sep 2025 Construction
- ocds-ted-330573-2025-1Unidade Local de Saúde Santa Maria, E.P.E.Not disclosed22 May 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Unidade Local de Saúde Santa Maria, E.P.E. and TEVA PHARMA-PROD. FARMACÊUT, LDA — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back